USARIEM
Natick, Massachusetts, 01760, United States
NCT Number: NCT05116397
The aim of this randomized, single-blind, placebo-controlled crossover trial is to determine the effects of graded hypercapnia (0, 2, and 4% inspired CO2) on endurance performance. Twelve healthy and fit young adults (men and women) will complete this study. Participants will perform experimental trials on 3 separate days (one each breathing 0%, 2%, and 4% inspired CO2-all with normal 21% oxygen). During each trial, they will perform 10 minutes of submaximal treadmill walking exercise and then complete a self-paced 2-mile treadmill run time-trial.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Natick, Massachusetts, 01760, United States
Participants will undergo baseline measurements of pulmonary function and maximal oxygen uptake (VO2max). They will then complete two familiarization trials, with 10 minutes of submaximal exercise (~40%VO2max) followed by a self-paced 2-mile treadmill time trial. Lastly, they will complete three experimental trials, repeating the same submaximal and time-trial exercise procedures while breathing the test gas (0%, 2%, or 4% CO2-all with normal 21% oxygen). During the experimental trials, arterialized capillary blood samples will be collected at rest breathing room air, at rest breathing the test gas, and during submaximal exercise at 40% VO2max breathing the test gas. The primary outcome is 2-mile treadmill time-trial performance. Secondary outcomes include ventilation, metabolic rate, heart rate, arterialized capillary pH/PCO2/HCO3, perceived exertion, dyspnea, leg discomfort, breathing descriptors, and headache ratings.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inspired gas content
Time frame: 30 minutes
Time to complete self-paced 2 mile treadmill time trial (min:sec)
Time frame: 30 minutes
Ventilation rate will be assessed using a pneumotachometer [L/min]
Time frame: 30 minutes
Oxygen consumption will be assessed using computerized indirect calorimetry [ml/kg/min]
Time frame: 30 minutes
Heart rate will be assessed using telemetry [beats per min]
Time frame: 30 minutes
Arterialized capillary pH will be assessed using a blood gas analyzer [Unitless]
Time frame: 30 minutes
Arterialized capillary pCO2 will be assessed using a blood gas analyzer [mmHg]
Time frame: 30 minutes
Arterialized capillary HCO3 will be assessed using a blood gas analyzer [mEq/L]
Time frame: 30 minutes
Rating of perceived exertion will be assessed using Borg's 6-20 scale [AU]
Time frame: 30 minutes
Rating of perceived dyspnea will be assessed using Borg's 0-10 scale [AU]
Time frame: 30 minutes
Rating of perceived leg discomfort will be assessed using Borg's 0-10 scale [AU]
Time frame: 30 minutes
Headache will be assessed using a visual analog scale [AU]
Time frame: 30 minutes
Breathing descriptors will be assessed by having participants check statements that apply to their breathing (e.g., breathing out requires more effort) [unitless]
United States Army Research Institute of Environmental Medicine
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05188651
COVID-19, COVID-19 Pandemic
Roma, RM, Italy
View Trial DetailsNCT04771663
Hypercapnia, Hypoxia
Kladno, Czechia
View Trial DetailsNCT05441007
Cardiac Output, High, Cardiovascular Diseases
Kladno, Czechia
View Trial DetailsNCT04304339
Acute Respiratory Failure, Hypercapnia
Versailles, A, France
View Trial Details